Evaluación de la enfermedad de Alzheimer en etapa temprana: biomarcadores y pruebas neuropsicológicas.

Resumen

EARLY EVALUATION OF ALZHEIMER DISEASE: BIOMARKERS AND NEUROPSYCHOLOGICAL TESTS

Alzheimer disease is a neurodegenerative condition that affects global, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer disease diagnosis is based primarily on clinical criteria. Since its early diagnosis allows clinical interventions when neurological damage is relatively mild, the development of early detection tools has become a major topic of interest. In this article, we review the main neurobiological and neuropsychological features of Alzheimer disease, analyzing the use of biomarkers and neuropsychological testing for early detection.